Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Clin Cancer Res. 2017 Jul 14;23(21):6686–6696. doi: 10.1158/1078-0432.CCR-17-1057

Table 1.

Fewer concurrent loss of heterozygosity and mutations of the VHL and PBRM1 genes in sarcomatoid ccRCC than in ccRCC, by P value (odds ratio)

3p 21–25 gene

Test VHL BAP1 SETD2 PBRM1
SccRCC vs grade 1 ccRCC 3.97E-02 (0.13) 1 (1) 1 (1) 1.93E-03 (0.04)
SccRCC vs grade 2 ccRCC 2.7E-06 (0.14) 1 (1.03) 2.11E-01 (0.43) 1.53E-05 (0.11)
SccRCC vs grade 3 ccRCC 1.49E-06 (0.13) 1 (1.01) 5.72E-01 (0.63) 1.66E-04 (0.14)
SccRCC vs grade 4 ccRCC 5.25E-02 (0.3) 6.97E-01 (0.58) 1 (1.21) 7.99E-03 (0.17)
SccRCC vs all ccRCC 1.79E-06 (0.15) 1 (0.96) 4.52E-01 (0.56) 1.79E-05 (0.13)